Get started
Author

Paul A. Fischer

Observed names: P A Fischer, P Fischer, P. Fischer, Paul A Fischer, Paul Fischer
Observed institutions: Rutgers, The State University of New Jersey, Merck & Co., Inc., Rahway, NJ, USA (United States), Harvard University, Massachusetts General Hospital, Bristol-Myers Squibb (United States), Center for Stroke Research Berlin, Charité - Universitätsmedizin Berlin
ORCID: 0000-0001-7673-8552
Observed ORCID: 0000-0001-7673-8552
OpenAlex ID: A5015773123
The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells.
1990 · F J Dumont, M R Melino, et al. · The Journal of Immunology · 355
Voltage-gated potassium channels regulate calcium-dependent pathways involved in human T lymphocyte activation.
1993 · C S Lin, R C Boltz, et al. · The Journal of Experimental Medicine · 241
β2-Microglobulin–Deficient NOD Mice Do Not Develop Insulitis or Diabetes
1994 · Linda S Wicker, Edward H Leiter, et al. · Diabetes · 235
Effects of pH and Low Density Lipoprotein (LDL) on PCSK9-dependent LDL Receptor Regulation
2007 · Timothy S. Fisher, Paola Lo Surdo, et al. · Journal of Biological Chemistry · 194
PDF
Characterization and Quantitation of NF-κB Nuclear Translocation Induced by Interleukin-1 and Tumor Necrosis Factor-α
1998 · Gloria J.F. Ding, Paul A. Fischer, et al. · Journal of Biological Chemistry · 191
Inhibition of T Cell Activation by Pharmacologic Disruption of the MEK1/ERK MAP Kinase or Calcineurin Signaling Pathways Results in Differential Modulation of Cytokine Production
1998 · Francis J Dumont, Mary Jo Staruch, et al. · The Journal of Immunology · 186
PDF
Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes.
1992 · L S Wicker, M C Appel, et al. · The Journal of Experimental Medicine · 179
The NOD Idd9 Genetic Interval Influences the Pathogenicity of Insulitis and Contains Molecular Variants of Cd30, Tnfr2, and Cd137
2000 · Paul A Lyons, Wayne W Hancock, et al. · Immunity · 166
PDF
Development of C5a receptor antagonists. Differential loss of functional responses.
1994 · Z D Konteatis, S J Siciliano, et al. · The Journal of Immunology · 151
Circulating T Cell Subpopulations Correlate With Immune Responses at the Tumor Site and Clinical Response to PD1 Inhibition in Non-Small Cell Lung Cancer
2018 · Nataly Manjarrez-Orduño, Laurence C. Menard, et al. · Frontiers in Immunology · 128
PDF
I-E+ nonobese diabetic mice develop insulitis and diabetes.
1993 · P L Podolin, A Pressey, et al. · The Journal of Experimental Medicine · 126
PDF
Linkage on Chromosome 3 of Autoimmune Diabetes and Defective Fc Receptor for IgG in NOD mice
1993 · Jan-Bas Prins, John A. Todd, et al. · Science · 102
Characterization and species distribution of high affinity GTP-coupled receptors for human rantes and monocyte chemoattractant protein 1.
1993 · G Van Riper, S Siciliano, et al. · The Journal of Experimental Medicine · 82
PDF
Correolide and Derivatives Are Novel Immunosuppressants Blocking the Lymphocyte Kv1.3 Potassium Channels
1999 · Gloria C. Koo, Joseph T. Blake, et al. · Cellular Immunology · 81
Role of the N-terminal Transmembrane Region of the Multidrug Resistance Protein MRP2 in Routing to the Apical Membrane in MDCKII Cells
2002 · Sara B.Mateus Fernández, Zsolt Holló, et al. · Journal of Biological Chemistry · 74
PDF
Genetic control of diabetes and insulitis in the nonobese diabetic mouse. Pedigree analysis of a diabetic H-2nod/b heterozygote.
1989 · L S Wicker, B J Miller, et al. · The Journal of Immunology · 60
Renal Cell Carcinoma (RCC) Tumors Display Large Expansion of Double Positive (DP) CD4+CD8+ T Cells With Expression of Exhaustion Markers
2018 · Laurence C. Menard, Paul Fischer, et al. · Frontiers in Immunology · 57
PDF
Arginine 206 of the C5a Receptor Is Critical for Ligand Recognition and Receptor Activation by C-terminal Hexapeptide Analogs
1995 · Julie A. DeMartino, Zenon D. Konteatis, et al. · Journal of Biological Chemistry · 55
Development of a novel GLUT4 translocation assay for identifying potential novel therapeutic targets for insulin sensitization
2008 · Franklin Liu, Qing Dallas-Yang, et al. · Biochemical Journal · 43
Epitopes and Mechanism of Action of the Clostridium difficile Toxin A-Neutralizing Antibody Actoxumab
2017 · Lorraine D. Hernandez, Heather K. Kroh, et al. · Journal of Molecular Biology · 42
A glucose-responsive insulin therapy protects animals against hypoglycemia
2018 · Ruojing Yang, Margaret Wu, et al. · JCI Insight · 39
PDF
Identification of Leu276 of the S1P1 Receptor and Phe263 of the S1P3 Receptor in Interaction with Receptor Specific Agonists by Molecular Modeling, Site-Directed Mutagenesis, and Affinity Studies
2006 · Qiaolin Deng, Joseph A. Clemas, et al. · Molecular Pharmacology · 36
Quantitative and temporal analysis of the cellular interaction of FK-506 and rapamycin in T-lymphocytes.
1994 · F J Dumont, C Kastner, et al. · Journal of Pharmacology and Experimental Therapeutics · 36
Miniaturization of Cell-Based β -Lactamase-Dependent FRET Assays to Ultra-High Throughput Formats to Identify Agonists of Human Liver X Receptors
2003 · Jayne Chin, Alan D. Adams, et al. · Assay and Drug Development Technologies · 33
Relationship between multiple biologic effects of rapamycin and the inhibition of pp70S6 protein kinase activity. Analysis in mutant clones of a T cell lymphoma.
1994 · F J Dumont, A Altmeyer, et al. · The Journal of Immunology · 33
Works count: 48
Citation count: 3,248
H-index: 29
I10-index: 37
Year
Topic
Type